Report

Small Cell Lung Cancer - A Giving Smarter Guide

ER

Ekemini Riley

Formerly Milken Institute
LB

LaTese Briggs

Formerly Milken Institute
YK

YooRi Kim

Formerly Milken Institute
EL

Erik Lontok

Formerly Milken Institute
Portrait of Melissa Stevens

Melissa Stevens

Executive Vice President, Milken Institute Strategic Philanthropy
Melissa Stevens is the executive vice president of Milken Institute Strategic Philanthropy, leading its work with individual and family philanthropists and foundations seeking to make a transformative, sustainable impact. Since co-founding Milken Institute Strategic Philanthropy in 2015, she has overseen the creation and execution of philanthropic strategies that have influenced more than $3 billion in capital and built an unmatched network for donors to collaborate and amplify their impact.
Topics
Philanthropy
Medical Philanthropy
Health
Medical Research and Innovation
Log in or create a free account to download
Full Report

Lung cancer has been one of the deadliest cancers in the United States. There are a number of challenges and unmet needs that act as barriers to desperately needed progress in small cell lung cancer (SCLC) research. The disease lacks new treatment options, there is insufficient access to biospecimens, and an overall poor understanding of underlying disease biology has prevented any chances for a cure.

This Giving Smarter Guide presents key issues to discuss the state of science relevant to SCLC and the challenges currently impeding research progress. It also includes recommendations on how strategic philanthropic investments can accelerate progress in SCLC.

Log in or create a free account to download
Full Report

Related Content